PIK3CA and neoplasm: Of note, most patients in this study were tested using an “old”, tumor-informed ctDNA assay tracking only PIK3CA and TP53 alterations via digital PCR or tagged-amplicon deep sequencing, as the whole-genome sequencing approach was used only for 9 patients.